A global unmet need
Emerging infectious diseases are responsible for more than one billion cases of illness annually and are a leading cause of death worldwide. Vector-borne diseases in particular are major public health threats with over half of the world’s population at risk, according to the World Health Organization.1
Accurate diagnosis is the key to effective treatment of infectious diseases. However, traditional laboratory tests are costly, complex, slow to develop, and not globally available. Kephera is addressing this critical need by enabling rapid development of diagnostics that support real-time clinical decisions—when and where they are most urgently needed.